PortfoliosLab logoPortfoliosLab logo
XPH vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XPH vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XPH achieves a 0.66% return, which is significantly higher than XLVI's -0.67% return.


XPH

1D
1.10%
1M
-4.74%
YTD
0.66%
6M
4.44%
1Y
37.98%
3Y*
13.07%
5Y*
3.50%
10Y*
3.44%

XLVI

1D
0.67%
1M
2.30%
YTD
-0.67%
6M
0.76%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XPH vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between XPH and XLVI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.54

XPH vs. XLVI - Sectors Allocation Comparison


Sectors
XPH
XLVI

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

100.6%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XPH
100.0%
XLVI

-

Basic Materials

XPH

-

XLVI

-

Communication Services

XPH

-

XLVI

-

Consumer Cyclical

XPH

-

XLVI

-

Consumer Defensive

XPH

-

XLVI

-

Energy

XPH

-

XLVI

-

Financial Services

XPH

-

XLVI
100.6%

Industrials

XPH

-

XLVI

-

Real Estate

XPH

-

XLVI

-

Technology

XPH

-

XLVI

-

Utilities

XPH

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XPH vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPH
XPH Risk / Return Rank: 5555
Overall Rank
XPH Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 5151
Sortino Ratio Rank
XPH Omega Ratio Rank: 4646
Omega Ratio Rank
XPH Calmar Ratio Rank: 6464
Calmar Ratio Rank
XPH Martin Ratio Rank: 6363
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XPH vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XPHXLVIDifference

Sharpe ratio

Return per unit of total volatility

1.77

Sortino ratio

Return per unit of downside risk

2.51

Omega ratio

Gain probability vs. loss probability

1.30

Calmar ratio

Return relative to maximum drawdown

3.19

Martin ratio

Return relative to average drawdown

11.37

XPH vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


XPHXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.77

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

1.33

-0.94

Drawdowns

XPH vs. XLVI - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for XPH and XLVI.


Loading charts...

Drawdown Indicators


XPHXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-48.03%

-8.14%

-39.89%

Max Drawdown (1Y)

Largest decline over 1 year

-11.97%

Max Drawdown (3Y)

Largest decline over 3 years

-23.57%

Max Drawdown (5Y)

Largest decline over 5 years

-31.63%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

Current Drawdown

Current decline from peak

-7.22%

-4.02%

-3.20%

Average Drawdown

Average peak-to-trough decline

-17.25%

-1.95%

-15.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.35%

Volatility

XPH vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


XPHXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.03%

Volatility (6M)

Calculated over the trailing 6-month period

16.77%

Volatility (1Y)

Calculated over the trailing 1-year period

21.52%

10.94%

+10.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.84%

10.94%

+9.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.10%

10.94%

+11.16%

XPH vs. XLVI - Expense Ratio Comparison

Both XPH and XLVI have an expense ratio of 0.35%.


Dividends

XPH vs. XLVI - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.66%, less than XLVI's 11.53% yield.


PositionTTM20252024202320222021202020192018201720162015
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.53%5.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XPH
SPDR S&P Pharmaceuticals ETF
0.66%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


XPH and XLVI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

XPH and XLVI have the same expense ratio: 0.35% per year.

XLVI has the higher dividend yield at 11.53%, compared with 0.66% for XPH.

XPH is categorized as Health & Biotech Equities, while XLVI is Derivative Income.

Portfolio Optimizer

Find the right allocation for XPH and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer